Literature DB >> 25222389

A simple schema for informed decision making about prostate cancer screening.

Andrew J Vickers, Kelly Edwards, Matthew R Cooperberg, Alvin I Mushlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25222389      PMCID： PMC4412472          DOI： 10.7326/M14-0151

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

Authors:  Sigrid Carlsson; Andrew J Vickers; Monique Roobol; James Eastham; Peter Scardino; Hans Lilja; Jonas Hugosson
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

2.  Patient-centered discussions about prostate cancer screening: a real-world approach.

Authors:  Barak Gaster; Kelly Edwards; Susan Brown Trinidad; Thomas H Gallagher; Clarence H Braddock
Journal:  Ann Intern Med       Date:  2010-11-16       Impact factor: 25.391

3.  Prostate cancer screening--the evidence, the recommendations, and the clinical implications.

Authors:  Roger Chou; Michael L LeFevre
Journal:  JAMA       Date:  2011-12-28       Impact factor: 56.272

4.  Early detection of prostate cancer: AUA Guideline.

Authors:  H Ballentine Carter; Peter C Albertsen; Michael J Barry; Ruth Etzioni; Stephen J Freedland; Kirsten Lynn Greene; Lars Holmberg; Philip Kantoff; Badrinath R Konety; Mohammad Hassan Murad; David F Penson; Anthony L Zietman
Journal:  J Urol       Date:  2013-05-06       Impact factor: 7.450

5.  Physician communication regarding prostate cancer screening: analysis of unannounced standardized patient visits.

Authors:  Bo Feng; Malathi Srinivasan; Jerome R Hoffman; Julie A Rainwater; Erin Griffin; Marko Dragojevic; Frank C Day; Michael S Wilkes
Journal:  Ann Fam Med       Date:  2013 Jul-Aug       Impact factor: 5.166

6.  Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.

Authors:  Amir Qaseem; Michael J Barry; Thomas D Denberg; Douglas K Owens; Paul Shekelle
Journal:  Ann Intern Med       Date:  2013-05-21       Impact factor: 25.391

7.  Decision boxes for clinicians to support evidence-based practice and shared decision making: the user experience.

Authors:  Anik Giguere; France Légaré; Roland Grad; Pierre Pluye; R Brian Haynes; Michel Cauchon; François Rousseau; Juliana Alvarez Argote; Michel Labrecque
Journal:  Implement Sci       Date:  2012-08-03       Impact factor: 7.327
  7 in total
  10 in total

Review 1.  The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.

Authors:  Katherine Fleshner; Sigrid V Carlsson; Monique J Roobol
Journal:  Nat Rev Urol       Date:  2016-12-20       Impact factor: 14.432

2.  Active Surveillance in Younger Men With Prostate Cancer.

Authors:  Michael S Leapman; Janet E Cowan; Hao G Nguyen; Katsuto K Shinohara; Nannette Perez; Matthew R Cooperberg; William J Catalona; Peter R Carroll
Journal:  J Clin Oncol       Date:  2017-03-27       Impact factor: 44.544

3.  The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening.

Authors:  Andrew J Vickers; James A Eastham; Peter T Scardino; Hans Lilja
Journal:  Urology       Date:  2016-02-02       Impact factor: 2.649

4.  An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.

Authors:  E David Crawford; Matt T Rosenberg; Alan W Partin; Matthew R Cooperberg; Michael Maccini; Stacy Loeb; Curtis A Pettaway; Neal D Shore; Paul Arangua; John Hoenemeyer; Mike Leveridge; Michael Leapman; Peter Pinto; Ian M Thompson; Peter Carroll; James Eastham; Leonard Gomella; Eric A Klein
Journal:  Urology       Date:  2016-07-19       Impact factor: 2.649

Review 5.  Problems with Numbers in Decision Aids for Prostate-specific Antigen Screening: A Critical Review.

Authors:  Sigrid V Carlsson; Andrew J Vickers; Jason P Gonsky; Jennifer L Hay; Jim C Hu
Journal:  Eur Urol       Date:  2020-12-09       Impact factor: 20.096

Review 6.  The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer.

Authors:  Claire L Tonry; Emma Leacy; Cinzia Raso; Stephen P Finn; John Armstrong; Stephen R Pennington
Journal:  Diagnostics (Basel)       Date:  2016-07-18

Review 7.  Prostate cancer screening-when to start and how to screen?

Authors:  Kimia Kohestani; Marina Chilov; Sigrid V Carlsson
Journal:  Transl Androl Urol       Date:  2018-02

8.  Appraising risk in active surveillance of localized prostate cancer.

Authors:  Anne Hogden; Kate Churruca; Frances Rapport; David Gillatt
Journal:  Health Expect       Date:  2019-05-16       Impact factor: 3.377

9.  Who and when should we screen for prostate cancer? Interviews with key opinion leaders.

Authors:  Sigrid Carlsson; Michael Leapman; Peter Carroll; Fritz Schröder; Peter C Albertsen; Dragan Ilic; Michael Barry; Dominick L Frosch; Andrew Vickers
Journal:  BMC Med       Date:  2015-11-27       Impact factor: 8.775

10.  Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care.

Authors:  Anita D Misra-Hebert; Grant Hom; Eric A Klein; Janine M Bauman; Niyati Gupta; Xinge Ji; Andrew J Stephenson; J Stephen Jones; Michael W Kattan
Journal:  Front Oncol       Date:  2018-06-28       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.